« Back to Record
Citation APA

Muralidharan, C., Huang, F., Enriquez, J. J., Wang, J. J., Nelson, J. J., Nargis, T., May, S. S., Chakraborty, A., Figatner, K. K., Navitskaya, S., Anderson, C. C., Calvo, V., Surguladze, D., Mulvihill, M. M., Yi, X., Sarkar, S., Oakes, S. S., Webb-Robertson, B.-J. M., Sims, E. E., Staschke, K. K., Eizirik, D. L., Nakayasu, E. S., Stokes, M. M., Tersey, S. S., & Mirmira, R. R. (2024). Inhibition of the Eukaryotic Initiation Factor-2-α Kinase PERK Decreases Risk of Autoimmune Diabetes in Mice. The Journal of clinical investigation, 134(12). doi:10.1172/JCI176136


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/376144

Muralidharan, C., Huang, F., Enriquez, J. J., Wang, J. J., Nelson, J. J., Nargis, T., May, S. S., Chakraborty, A., Figatner, K. K., Navitskaya, S., Anderson, C. C., Calvo, V., Surguladze, D., Mulvihill, M. M., Yi, X., Sarkar, S., Oakes, S. S., Webb-Robertson, B.-J. M., Sims, E. E., Staschke, K. K., Eizirik, D. L., Nakayasu, E. S., Stokes, M. M., Tersey, S. S., & Mirmira, R. R. (2024). Inhibition of the Eukaryotic Initiation Factor-2-α Kinase PERK Decreases Risk of Autoimmune Diabetes in Mice. The Journal of clinical investigation, 134(12). doi:10.1172/JCI176136